The FDA has accepted for Priority Review the sBLA for aflibercept injection 8mg for the treatment of macular edema following RVO and for monthly dosing in approved indications.

Adverse social determinants of health are associated with worse visual outcomes in primary congenital glaucoma.

Specialty contact lenses have a favorable benefit-cost ratio for patients with irregular cornea and ocular surface diseases.

Among US adults, frequent users of social media exhibited heightened levels of irritability, beyond that explained by depression or anxiety.

HealthDay News — Two widely consumed food additive mixtures may increase type 2 diabetes incidence, according to a study published online April 8 in PLOS Medicine.

People covered by Medicaid are just as likely as those with private insurance to face a copay or other charge for sending a message to their physician or other provider through a portal.

Five years after COVID-19 first hit the United States, scientists are already brainstorming how to stop the next big virus.

The risk for long COVID among pregnant individuals is lower than among matched nonpregnant women. HealthDay News — The risk for long COVID among pregnant individuals is lower than among matched ...

A new drug application has been submitted for Brimochol™ PF (Tenpoint Therapeutics Ltd.) for the treatment of presbyopia.

Using regression analysis, the investigators found that the control of axial growth with ortho-K treatment was better in the summer than in the winter (β=-0.05; P <.001). They observed a similar ...

HALT spectacle lenses can significantly reduce myopic progression independently from, or as a supplement to, low-dose atropine.

The FDA has again issued a CRL to Aldeyra regarding the New Drug Application for reproxalap for the treatment of dry eye disease.